NEW YORK (GenomeWeb) – UK researchers have developed a blood test to differentiate men with prostate cancer who may benefit from targeted treatments.
Registering provides access to this and other free content.
Already have an account?Login Now.
A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.
UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.
Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.
In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.
This webinar will discuss the benefits of using unique molecular indices to overcome some challenges associated with next-generation sequencing panels.
This webinar will discuss a molecular barcode-based error correction method that enables combined mutation detection and DNA copy number profiling through circulating tumor DNA sequencing.